NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









TECLens, Inc.

TECLens, Inc.

Private
Stamford, ConnecticutHealthcare & Life Scienceshttps://teclens.com/

Last Round

Series A

Feb 11, 2025

Total Funding Raised

$9.3M

Company Overview

TECLens, Inc. is a medical device company developing a non-invasive, personalized corneal cross-linking technology for vision correction.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Precision Medicine, Clinical Trials, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales, Usage-Based SaaS, Hardware + Subscription

AI Layer

Non-AI

Keywords

corneal cross-linkingqCXLCXLnon-invasive vision correctionpresbyopia treatmentCXLens systemLASIK alternativeophthalmic medical devicecorneal reshapingrefractive error correctionreal-time ultrasound monitoringreading glasses alternativekeratoconus treatmentmyopia treatmentmedical device sales

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

TECLens, Inc. Comps

Public and private peers based on sector, stage, and business model.

TECLens, Inc. comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

TECLens, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AFeb 11, 2025
View all Funding Rounds

Key People

Founding team and executive leadership

Thomas Dunlap

Chief Executive Officer

Executive Team

Rob Hughes

CFO

Executive Team

Patrick Lopath

Chief Operating Officer

Executive Team

TECLens, Inc. Investors

Notable investors and investment history

TECLens, Inc. investors
InvestorRounds
Yonjin CapitalSeries A
RimonciSeries A
Johnson & Johnson Innovation - JJDC, Inc.Series A
View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 11, 2025

    Monthly visitors grew 97% MoM, reaching 1.9K.

  • May 2, 2025

    Monthly visitors increased 147% MoM.

View all signals

TECLens, Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

TECLens, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about TECLens, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersStamford, Connecticut
Employee Range12
Year Founded2013
Last FundingFeb 11, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.